Bridges2Scale: Testing implementation strategies for an intervention among young people affected by AIDS
Project Number5R01HD112323-02
Contact PI/Project LeaderSSEWAMALA, FRED M Other PIs
Awardee OrganizationWASHINGTON UNIVERSITY
Description
Abstract Text
PROJECT ABSTRACT
Sub-Saharan Africa (SSA), a region dominated by low-resource communities and relatively poor families, is
experiencing rising HIV prevalence among adolescents and youth (AY). Household economic hardships heighten
the risk for AY’s engaging in health-compromising behaviors and their poor engagement with care. This
increases their risk for contracting and transmitting HIV and non-adherence to ART treatment. Economic
empowerment (EE) interventions have demonstrated substantial promise in reducing HIV-related risk-taking
behaviors, and improving ART treatment adherence and mental health outcomes. Based on 10+ years of
research utilizing savings-led EE interventions focused on HIV prevention, care and support for AY affected by
HIV [AYaAIDS] (including AY living with HIV [AYLHIV]; and AY orphaned by AIDS [AYoAIDS] in SSA, our group
has demonstrated the effectiveness of a multi-component EE intervention, Bridges, in four NIH-funded
randomized control trials (RCT) in Uganda
(R01
HD070727, R01HD074949, R34MH081763, R01MH113486),
and one foundation-funded study in Kenya. Bridges involves: 1) financial literacy training (FLT) and mentorship;
2) family income-generating activities (IGA); and 3) incentivized savings via a matched Youth Development
Account (YDA). Bridges has demonstrated robust effects on HIV-related risk-taking behaviors, ART adherence,
mental health, psychosocial outcomes, educational achievement, family economics, and family cohesion. Yet,
scaling EE interventions has been a challenge, signaling the need to identify and test scale-up strategies and
examine determinants of implementation and sustainment. In Bridges2Scale, we will compare two multifaceted
strategies (standard vs enhanced) for scaling Bridges in a two-arm Hybrid III effectiveness-implementation
cluster RCT. The standard implementation strategy has been applied in our prior RCTs and involves educational
meetings that prepare staff to deliver Bridges with minimal disruption to site workflow. This will be compared to
an enhanced strategy that will be developed using Implementation Mapping. We will use the public school system
to recruit 1440 AYaAIDS (ages 13-17 years) from 48 schools in the Greater Masaka region of Uganda, a region
with 11.7% HIV prevalence. Schools will be the unit of randomization (n=24 schools per arm; n=720 students
per arm). Four specific aims guide our study: Aim 1. Compare the implementation effectiveness of the standard
implementation strategy vs. an enhanced implementation strategy; Aim 2. Determine the clinical effectiveness
of Bridges implemented via a standard vs. enhanced implementation strategy; Aim 3. Explore implementation
processes, mechanisms, and determinants; and Aim 4. Compare the cost and cost-effectiveness of the two
implementation strategies. The study will address a critical challenge: how to best support the implementation,
scale-up, and sustainment of EE interventions, which have been proven to be highly efficacious in improving
youth-focused HIV prevention, care, and support outcomes, but are yet to be widely scaled up.
Public Health Relevance Statement
PROJECT NARRATIVE
Economic empowerment (EE) interventions have demonstrated substantial promise in reducing HIV-related
risk-taking behaviors, and improving ART treatment adherence and mental health outcomes. Yet, scaling EE
interventions has been a challenge, signaling the need to identify and test scale-up strategies and examine
determinants of implementation and sustainment. Using a two-arm Hybrid III effectiveness-implementation
cluster randomized clinical trial, the Bridges2Scale study will address a critical challenge, which is: how to best
support the implementation, scale-up, and sustainment of EE interventions, which have been proven to be
highly efficacious in improving youth-focused HIV prevention, care, and support outcomes, but are yet to be
widely scaled up.
NIH Spending Category
No NIH Spending Category available.
Project Terms
AIDS preventionAcquired Immunodeficiency SyndromeAddressAdherenceAdolescentAffectAfrica South of the SaharaAgeBehaviorBusinessesCaringClinical effectivenessCommunitiesContractsDevelopmentEconomicsEducationEducational StatusEffectivenessEnsureEvidence based practiceFamilyFoundationsFundingFutureGovernmentHIVHIV SeronegativityHealthHouseholdHybridsIncentivesIncomeInterventionInterviewInvestmentsKenyaMapsMental HealthMentorshipMethodsModificationOutcomeOutcome MeasureParticipantPenetrationPerceptionPersonsPreparationPrevalenceProcessProtocols documentationRandomizedRandomized, Controlled TrialsReduce health disparitiesResearchResearch PriorityResource-limited settingRiskRisk TakingSavingsSchoolsSignal TransductionSiteStructureStudentsSystemTestingTrainingUgandaUnderserved PopulationUnited States National Institutes of HealthViralYoutharmcohesioncommunity partnerscomparative cost effectivenesscostcost comparisoncost effectivenessdesigneconomic evaluationeffectiveness evaluationempowermentexperiencefinancial literacyimplementation determinantsimplementation outcomesimplementation processimplementation strategyimplementation/effectivenessimprovedmeetingsmemberpost interventionpre-exposure prophylaxisprimary outcomepsychosocial outcomepublic-private partnershiprandomized, clinical trialsrecruitscale upsexual risk takingstandardize measuretheoriestransmission processtreatment adherence
Eunice Kennedy Shriver National Institute of Child Health and Human Development
CFDA Code
865
DUNS Number
068552207
UEI
L6NFUM28LQM5
Project Start Date
23-August-2023
Project End Date
31-July-2028
Budget Start Date
01-August-2024
Budget End Date
31-July-2025
Project Funding Information for 2024
Total Funding
$633,612
Direct Costs
$513,663
Indirect Costs
$119,949
Year
Funding IC
FY Total Cost by IC
2024
Eunice Kennedy Shriver National Institute of Child Health and Human Development
$633,612
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R01HD112323-02
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01HD112323-02
Patents
No Patents information available for 5R01HD112323-02
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01HD112323-02
Clinical Studies
No Clinical Studies information available for 5R01HD112323-02
News and More
Related News Releases
No news release information available for 5R01HD112323-02
History
No Historical information available for 5R01HD112323-02
Similar Projects
No Similar Projects information available for 5R01HD112323-02